Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EA stock price vs XRAY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at XRAY's multiple
Needs XRAY P/E.
Implied fair value · at EA's multiple
Needs Annual EPS is negative, EA P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ELECTRONIC ARTS INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
DENTSPLY SIRONA Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Activision Blizzard, Inc.
EA vs ATVI
Unity Software Inc.
EA vs U
MICROSOFT CORP
EA vs MSFT
TAKE TWO INTERACTIVE SOFTWARE INC
EA vs TTWO
GameStop Corp.
EA vs GME
HENRY SCHEIN INC
EA vs HSIC
PATTERSON COMPANIES, INC.
EA vs PDCO
Envista Holdings Corp
EA vs NVST
DANAHER CORP /DE/
EA vs DHR
3M CO
EA vs MMM
RESMED INC
EA vs RMD
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe EA can sustain its current profitability and modest growth, then avoid initiating a new position at $209.86 because the stock already sits above the DCF range and well above XRAY-implied valuation, despite EA's superior fundamentals versus XRAY.
EA trades at a large premium versus XRAY on almost every operating and valuation metric, but the key issue is that XRAY-based implied price of $21.86 is far below EA's current $209.86 price. The gap is driven less by EA weakness than by XRAY's distressed fundamentals and distorted valuation ratios.
Supporting Metrics
